Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Biofrontera Pharmaceuticals Holding AG, bioLeads deal

Biofrontera acquired all the assets of drug discovery company bioLeads,

Read the full 101 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE